论文部分内容阅读
目的观察蒲地蓝联合利巴韦林喷雾剂治疗小儿普通型手足口病的临床效果。方法选取2014年12月-2015年5月在医院治疗的小儿普通型手足口病患儿65例,根据治疗方法的不同分为观察组34例和对照组31例。对照组给予利巴韦林气雾剂治疗,观察组在对照组治疗的基础上给予蒲地蓝治疗。比较2组患者的临床疗效。结果观察组总有效率为97.06%显著高于对照组的80.65%,差异有统计学意义(P<0.05)。结论蒲地蓝联合利巴韦林喷雾剂治疗小儿普通型手足口病具有疗效显著、安全可靠等优点,值得临床推广应用。
Objective To observe the clinical effect of Pipidrin combined with ribavirin spray in the treatment of common hand, foot and mouth disease in children. Methods Sixty-five children with HFMD in our hospital from December 2014 to May 2015 were divided into observation group (34 cases) and control group (31 cases) according to the different treatment methods. The control group was given ribavirin aerosol, and the observation group was treated with pomaline on the basis of the control group. The clinical effects of two groups were compared. Results The total effective rate was 97.06% in the observation group was significantly higher than 80.65% in the control group, the difference was statistically significant (P <0.05). Conclusions The combination of Ptidium Blue and Ribavirin Spray for the treatment of common hand, foot and mouth disease in children has the advantages of significant curative effect, safety and reliability, which is worthy of clinical application.